à¤¨à¤µà¤à¤¾à¤¤ à¤à¤à¤à¤°à¤à¥ à¤à¤«à¤à¤à¤à¤

टेक्नोलॉजी
Modern

पोर्टेबल
Yes

फंक्शन
Hospital Use

एप्लीकेशन
For Hospital amd Clinic Purpose

रंग
Multicolor

उपयोग करें
Medical Use

शर्त
New

Minimum Order Quantity
1 टुकड़ा

आपूर्ति की क्षमता
प्रति सप्ताह

डिलीवरी का समय
हफ़्ता

मुख्य घरेलू बाज़ार
ऑल इंडिया

About à¤¨à¤µà¤à¤¾à¤¤ à¤à¤à¤à¤°à¤à¥ à¤à¤«à¤à¤à¤à¤

Labsystems Diagnostics' Neonatal IRT FEIA is a fluorometric enzyme immunoassay for the quantitative determination of human immuno reactive trypsinogen (IRT) from blood samples dried on filter paper as a primary test for screening of babies for cystic fibrosis (CF).

overview

IRT is eluted from dried blood disks simultaneously forming a sandwich between the solid phase, coated with an antibody that recognizes Trypsinogen-1 (IRT-1) and a second antibody, which is labeled with horseradish peroxidase (HRP).

Technical Specifications

Neonatal IRT FEIA, 10 solid plates (96), 960 wells 6199831
Neonatal IRT FEIA, 10 strip plates (12x8), 960 wells 6199832

Benefits

Fluorescence detection provides high sensitivity
Easy to perform, similar procedure than in TSH and 17-OHP kits
Stable reagents
Assay is compatible with Labsystems Diagnostics NS2400 automation system

Advanced Neonatal Diagnostic Solution

The Neonatal IRT FEIA employs cutting-edge technology to deliver rapid and reliable results, crucial for the early identification of specific neonatal conditions. Its modern design helps healthcare professionals streamline the screening process, ultimately improving newborn care outcomes across medical settings.

Portable and Versatile for Clinical Environments

Designed for portability, this device provides flexibility in its application, making it suitable for both large hospitals and smaller clinics. Its multicolor interface contributes to straightforward operation, ensuring adaptability in busy clinical workflows without compromising on performance or accuracy.

FAQs of Neonatal IRT FEIA:

Q: How is the Neonatal IRT FEIA used in hospital and clinic settings?

A: The Neonatal IRT FEIA is utilized by medical professionals for neonatal screening in both hospitals and clinics. Its portable nature allows easy movement between departments or patient rooms, enabling prompt testing with minimal setup time.

Q: What technology does the Neonatal IRT FEIA employ for medical diagnostics?

A: This device uses modern Fluorescence Enzyme Immunoassay (FEIA) technology, ensuring high precision and rapid results in neonatal screening, greatly supporting early diagnosis and intervention.

Q: When is the ideal time to utilize this device for newborns?

A: Healthcare professionals typically use the Neonatal IRT FEIA soon after birth during routine neonatal checkups, ensuring the timely identification and management of potential health concerns.

Q: Where can the Neonatal IRT FEIA be sourced in India?

A: The product is manufactured, supplied, exported, and distributed across India. Hospitals and clinics can obtain it directly from authorized distributors or the manufacturer.

Q: What is the process of operating the Neonatal IRT FEIA?

A: Operating the Neonatal IRT FEIA involves collecting a neonatal blood sample, inserting it into the device, and following on-screen instructions through its multicolor display. Results are produced within a short time, allowing for prompt clinical decisions.

Q: How does using this device benefit newborn care in clinical practice?

A: By enabling early detection of metabolic and genetic disorders, the Neonatal IRT FEIA supports timely intervention, potentially improving long-term outcomes for newborns and streamlining workflows within healthcare facilities.